pubmed-article:20855369 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:20855369 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
pubmed-article:20855369 | lifeskim:mentions | umls-concept:C0037303 | lld:lifeskim |
pubmed-article:20855369 | lifeskim:mentions | umls-concept:C0003842 | lld:lifeskim |
pubmed-article:20855369 | lifeskim:mentions | umls-concept:C0597357 | lld:lifeskim |
pubmed-article:20855369 | lifeskim:mentions | umls-concept:C0006669 | lld:lifeskim |
pubmed-article:20855369 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
pubmed-article:20855369 | lifeskim:mentions | umls-concept:C0231491 | lld:lifeskim |
pubmed-article:20855369 | lifeskim:mentions | umls-concept:C2713633 | lld:lifeskim |
pubmed-article:20855369 | pubmed:issue | 10 | lld:pubmed |
pubmed-article:20855369 | pubmed:dateCreated | 2010-9-21 | lld:pubmed |
pubmed-article:20855369 | pubmed:abstractText | Calcitonin gene-related peptide (CGRP) is a neuronal messenger in intracranial sensory nerves and is considered to play a significant role in migraine pathophysiology. | lld:pubmed |
pubmed-article:20855369 | pubmed:language | eng | lld:pubmed |
pubmed-article:20855369 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20855369 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:20855369 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20855369 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20855369 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20855369 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20855369 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20855369 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20855369 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20855369 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20855369 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:20855369 | pubmed:month | Oct | lld:pubmed |
pubmed-article:20855369 | pubmed:issn | 1468-2982 | lld:pubmed |
pubmed-article:20855369 | pubmed:author | pubmed-author:EdvinssonLars... | lld:pubmed |
pubmed-article:20855369 | pubmed:author | pubmed-author:de VriesRenéR | lld:pubmed |
pubmed-article:20855369 | pubmed:author | pubmed-author:DanserA H... | lld:pubmed |
pubmed-article:20855369 | pubmed:author | pubmed-author:DirvenClemens... | lld:pubmed |
pubmed-article:20855369 | pubmed:author | pubmed-author:SävelandHansH | lld:pubmed |
pubmed-article:20855369 | pubmed:author | pubmed-author:MaassenVanDen... | lld:pubmed |
pubmed-article:20855369 | pubmed:author | pubmed-author:NilssonElisab... | lld:pubmed |
pubmed-article:20855369 | pubmed:author | pubmed-author:ChanKayi YKY | lld:pubmed |
pubmed-article:20855369 | pubmed:author | pubmed-author:EftekhariSaje... | lld:pubmed |
pubmed-article:20855369 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:20855369 | pubmed:volume | 30 | lld:pubmed |
pubmed-article:20855369 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:20855369 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:20855369 | pubmed:pagination | 1233-40 | lld:pubmed |
pubmed-article:20855369 | pubmed:meshHeading | pubmed-meshheading:20855369... | lld:pubmed |
pubmed-article:20855369 | pubmed:meshHeading | pubmed-meshheading:20855369... | lld:pubmed |
pubmed-article:20855369 | pubmed:meshHeading | pubmed-meshheading:20855369... | lld:pubmed |
pubmed-article:20855369 | pubmed:meshHeading | pubmed-meshheading:20855369... | lld:pubmed |
pubmed-article:20855369 | pubmed:meshHeading | pubmed-meshheading:20855369... | lld:pubmed |
pubmed-article:20855369 | pubmed:meshHeading | pubmed-meshheading:20855369... | lld:pubmed |
pubmed-article:20855369 | pubmed:meshHeading | pubmed-meshheading:20855369... | lld:pubmed |
pubmed-article:20855369 | pubmed:meshHeading | pubmed-meshheading:20855369... | lld:pubmed |
pubmed-article:20855369 | pubmed:meshHeading | pubmed-meshheading:20855369... | lld:pubmed |
pubmed-article:20855369 | pubmed:meshHeading | pubmed-meshheading:20855369... | lld:pubmed |
pubmed-article:20855369 | pubmed:meshHeading | pubmed-meshheading:20855369... | lld:pubmed |
pubmed-article:20855369 | pubmed:meshHeading | pubmed-meshheading:20855369... | lld:pubmed |
pubmed-article:20855369 | pubmed:meshHeading | pubmed-meshheading:20855369... | lld:pubmed |
pubmed-article:20855369 | pubmed:meshHeading | pubmed-meshheading:20855369... | lld:pubmed |
pubmed-article:20855369 | pubmed:year | 2010 | lld:pubmed |
pubmed-article:20855369 | pubmed:articleTitle | Effect of the calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant in human cranial arteries. | lld:pubmed |
pubmed-article:20855369 | pubmed:affiliation | Department of Internal Medicine, Lund University Hospital, Lund, Sweden. lars.edvinsson@med.lu.se | lld:pubmed |
pubmed-article:20855369 | pubmed:publicationType | Journal Article | lld:pubmed |